Publication Cover
Redox Report
Communications in Free Radical Research
Volume 9, 2004 - Issue 6
176
Views
6
CrossRef citations to date
0
Altmetric
Short, Referred Papers

The inhibitory effect of alacepril, an angiotensin-converting enzyme inhibitor, on endothelial inflammatory response induced by oxysterol and TNF-α

, , , , , , , & show all
Pages 354-359 | Published online: 20 Nov 2013

REFERENCES

  • Itoh K, Yoshida S, Fukuda M. The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits - critical analysis with new ultrasound technique. Jpn Circ J1994; 58: 844-854.
  • Miyazaki M, Takai S. Antiatherosclerotic effect of alacepril, anangiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. Hypertens Res 1999; 22: 49–54.
  • Russell JC, Graham SE, Amy RM, Dolphin PJ. Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril. J Cardiovasc Pharmacol 1998; 31: 971–977.
  • Suzuki M, Teramoto S, Katayama H, Ohga E, Matsuse T, Ouchi Y. Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages. J Asthma 1999; 36: 665–670.
  • Noda Y, Anzai K, Mori A, Kohno M, Shinmei M, Packer L. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem Mol Biol Intl 997; 42: 35-44.
  • Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963–20966.
  • Dong ZM, Wagner DD. Leukocyte-endothelium adhesion molecules in atherosclerosis. J Lab Clin Med 1998; 132: 369–375.
  • Yoshida N, Manabe H, Terasawa Yet al. Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein. Biofactors 2000; 13: 279–288.
  • Matsumoto K, Miyazaki H, Fujii T, Yoshida K, Amejima H, Hashimoto M. Disposition and metabolism of the novel antihypertensive agent alacepril in rats. Arzneimittelforschung 1986; 36: 40–46.
  • Mak IT, Freedman AM, Dickens BF, Weglicki WB. Protective effects of sulfhydryl-containing angiotensin-converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol 1990; 40: 2169–2175.
  • Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol 1992; 19: 330–340.
  • Cominacini L, Pasini A, Garbin U et al. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Am J Hypertens 2002; 15: 891–895.
  • Mira ML, Silva MM, Manso CF. The scavenging of oxygen free radicals by angiotensin-converting enzyme inhibitors: the importance of the sulfhydryl group in the chemical structure of the compounds. Ann NY Acad Sci 1994; 723: 439–441.
  • Lizard G, Gueldry S, Sordet 0 et al. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 1998; 12: 1651–1663.
  • True AL, Rahman A, Malik AB. Activation of NF-kappaB induced by H(2)0(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol 2000; 279: L302–L311.
  • Higgins JP. Can angiotensin-converting enzyme inhibitors reverse atherosclerosis? South Med J2003; 96: 569–579.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.